Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction
A qualified healthcare provider should evaluate whether GLP-1 treatment is appropriate for any individual under 30 years old, weighing comorbidities, weight loss goals, diabetes status, and long-term safety data gaps
Back DiMarchi, R Efendic, S (1997) 'Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity', US Patent US6191102B1.Back Drucker, DJ, Habener, JF, Holst, JJ (1 Dec 2017) 'Discovery, characterization, and clinical development of the glucagon-like peptides', Journal of Clinical Investigation , 127/12, 4217-27
The goal is to lose mostly fat, preserve your muscle, and build a body that is strong, functional, and sustainable long term
GoodGirlRx does not guarantee specific weight loss results